Table 2.

Comparison of incidence of adverse events during treatment for patients receiving colistin or tigecycline

Adverse events	Treatment group		Total (N = 65)	P value
	Colistin (N = 34)	Tigecycline (N = 31)
Overall adverse events	23 (67.6)	13 (41.9)	36 (55.3)	0.047a
Renal impairment	20 (58.8)	7 (22.6)	27 (41.5)	0.003 a
Liver enzymes abnormalities	1 (2.9)	1 (3.2)	2 (3.1)	>0.999b
Nausea and vomiting	0 (0)	4 (12.9)	4 (6.2)	0.046b
Skin rash	1 (2.9)	0 (0)	1 (1.5)	>0.999b
Others	5 (14.7)	2 (6.4)	7 (10.7)	0.430 a

Data expressed as n (%)

^aChi-square test

^bFisher's exact test